Gå til innholdet
Menu
  • For animals
    For health
    For you

  • Our solutions
    support healthy
    growth in
    aquaculture

  • Supporting our
    customers in
    ever better ways

  • Supporting those
    who raise and
    care for fish

  • We make
    aquaculture
    progress

PHARMAQ Insight

Sign up for newsletter

PHARMAQ ACHIEVEMENTS

1987

We launched the first vaccine ever against cold water vibriosis - ”saving” the Norwegian salmon industry and dramatically reduced the use of antibiotics

1991

Introduction of the world’s first oil based fish vaccine offering protection against furunculosis

1996

Our State-of-the-art GMP production facility for fish vaccines opens in Overhalla, Norway

1997

The first six component vaccine ever introduced in Norway. Includes protection against IPNV and winter ulcer.

1998

ALPHA MAX® for bath treatment against salmon lice available in the Norwegian- and the Faroese market

2001

Established office in Puerto Montt, Chile, later to become PHARMAQ AS Chile Ltda.

2002

The first European fish vaccine ever approved by the Canadian authorities

2004

Obtained approval in UK for the first virus vaccine for fish - protection against IPNV and furunculosis

2004

PHARMAQ established 23 July by 'management buy out' of the Aquatic Animal Health business of Alpharma Inc.

2007

Launch of our first generation SRS vaccine in Chile

2008

MA approved for ALPHA JECT micro® 6 in Norway, the first six-component micro dose vaccine available

2008

Sales license for ALPHA JECT® micro 3 in Chile, the first trivalent SRS micro dose vaccine available

2008

PHARMAQ opened office in Vietnam, later to become PHARMAQ Ltd. VN

2008

Acquisition of PHARMAQ by Orkla and Kverva

2009

Extensive field trial of the first Pangasius vaccine started in Vietnam

2010

PHARMAQ’s first ISA vaccine received a provisional marketing authorisation from the Chilean authorities

2011

PHARMAQ officially opened its PHARMAQ Turkey Ltd office in Izmir in May

2011

PHARMAQ signed a long term agreement with Norwegian Institute of Public Health for lease of virus antigen production facilities in Norway

2011

As the first fish vaccine commercially available in Vietnam, ALPHA JECT Panga 1 received a observation license

2012

PHARMAQ Holding acquires Havbruksinstituttet AS, renamed as PHARMAQ Analytiq

2013

Permira acquired PHARMAQ May 2013

2014

PHARMAQ and The Ministry of Agriculture and Rural Development in Vietnam signed agreement of co-operation

2015

PHARMAQ is now part of Zoetis, the world leader in animal health. For more information about our owner, visit www.zoetis.com

2016

PHARMAQ launched our first attenuated live vaccine in Chile against SRS, ALPHA JECT LiVac® SRS

Future

We make aquaculture progress!

Norway

Head office
Production facility
PHARMAQ AS
Skogmo Industriområde
Industrivegen 50
7863 Overhalla, Norway
Tel:+47 74 28 08 00
Fax:+47 74 28 08 01

Oslo office
PHARMAQ AS
Harbitzalléen 2A, 0275 Oslo,
P.O.Box 267 Skøyen, N-0213 Oslo, Norway
Tel: +47 23 29 85 00
Fax: :+47 23 29 85 01
customer.service​@pharmaq.no

Chile

PHARMAQ AS Chile Ltda.
Anibal Pinto # 200, oficina 61,
Puerto Montt, Chile
Tel: +56 65 248 3091
customer.service​@pharmaq.no

United Kingdom

PHARMAQ Ltd.
Unit 15 Sandleheath Industrial Estate,
Fordingbridge,
Hampshire SP6 1PA,
United Kingdom
Tel: +44 1425 656081
Fax: +44-1425 657992
orders@pharmaq.no

Terms & Conditions of Purchase
Terms & Conditions of Sale

Turkey

PHARMAQ Veteriner Ecza Deposu ve Su Ürünleri Tic.Ltd.Şti
KARACAOGLAN MAH. 6166 SK. 21 A BORNOVA/ IZMIR Turkiye
Tel: +90 232 422 23 10
Fax:+90 232 422 32 27
customer.service​@pharmaq.no

Vietnam

PHARMAQ Ltd. VN
AGREX Office Building, Floor 11th
58 Vo Van Tan Street, District 3
Ho Chi Minh City
Vietnam
Tel : +84 8 3930 1991
Fax : +84 8 3930 1997
customer.service​@pharmaq.no

Panama

PHARMAQ CA Panama Inc. <